𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PP-5-16 A Study of Postoperative Adjuvant Chemotherapy of 5′-DFUR in Breast Cancer Patients (1st Report) — On Compliance and Safety — “The 5′-BC Study Group” (5′-DFUR Adjuvant Chemotherapy for Breast Cancer Study Group)

✍ Scribed by H. Koyama; O. Abe; J. Uchino; W. Hayasaka; R. Abe; M. Izuo; K. Enomoto; T. Tominaga; H. Watanabe; M. Yoshida; T. Taguchi; T. Senoo; T. Toge; Y. Monden; T. Hattori; Y. Nomura; K. Sugimachi; H. Nakazato; Y. Ohashi; S. Miura; T. Morimoto; K. Asaishi; I. Kimijima; J. Ohta; H. Sonoo; M. Toi; S. Yamaguchi

Book ID
116168166
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
172 KB
Volume
32
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized study of 5-FU and ccnu in pan
Randomized study of 5-FU and ccnu in pancreatic cancer: Report of the veterans administration surgical adjuvant cancer chemotherapy study group
✍ Charles Frey; Patrick Twomey; Rubert Keehn; Daniel Elliott; George Higgins 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

Between the years 1973-1977, 152 male patients from 28 participating Veterans Hospitals with histologically proven nonresectable cancer of the pancreas were randomized in a two-arm study. The treated group was to receive combination chemotherapy with 5-FU and CCNU, and the controls were to receive n

A retrospective study of earliest indica
A retrospective study of earliest indicators of recurrence in patients on eastern cooperative oncology group adjuvant chemotherapy trials for breast cancer. A preliminary report
✍ Kishan J. Pandya; Eleanor T. McFadden; Leslie A. Kalish; Douglass C. Tormey; Sam 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 3 views

A retrospective review of the Eastern Cooperative Oncology Group adjuvant chemotherapy studies EST 5177 and EST 6177 was performed in order to ascertain the first indicator of relapse in women with breast cancer and pathologically positive axillary lymph nodes. Of 856 evaluable patients, 208 have re

Randomized adjuvant trial to evaluate th
Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-year results from the nishi-nippon group of the adjuvant chemoendocrine therapy for breast cancer organization
✍ Masakazu Toil; Takao Hattori; Masanobu Akagi; Kiyoshi Lnokuchi; Kunzo Orita; Kei 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b